High total-to-HDL cholesterol ratio predicting deterioration of ankle brachial index in Asian type 2 diabetic subjects

Diabetes Research and Clinical Practice

Volumn 79, Issue 3, 2008, Pages 419-426

  Lee, I Te ^a,b   Huang, Chien Ning ^b   Lee, Wen Jane ^a,c   Lee, Hong Shen ^b   Sheu, Wayne Huey Herng ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Ankle brachial index; Peripheral vascular disease; Total to HDL cholesterol ratio; Type 2 diabetes

Indexed keywords

CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; ASIAN; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DETERIORATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RISK FACTOR;

AGED; ANKLE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BRACHIAL ARTERY; CHINA; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK FACTORS;

EID: 39449123289     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.10.002     Document Type: Article

References (66)

1. Walters D.P., Gatling W., Mullee M.A., and Hill R.D. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet. Med. 9 (1992) 710-715
2. Most R.S., and Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6 (1983) 87-91
3. Siitonen O.I., Niskanen L.K., Laakso M., Siitonen J.T., and Pyorala K. Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care 16 (1993) 16-20
4. Heidrich H., Wenk R., and Hesse P. Frequency of asymptomatic peripheral arterial disease in patients entering the department of general and internal medicine of a general-care hospital. Vasa 33 (2004) 63-67
5. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N. Engl. J. Med. 344 (2001) 1608-1621
6. Federman D.G., Bravata D.M., and Kirsner R.S. Peripheral arterial disease. A systemic disease extending beyond the affected extremity. Geriatrics 59 (2004) 26, 29-30, 32
7. McKenna M., Wolfson S., and Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87 (1991) 119-128
8. Vogt M.T., McKenna M., Anderson S.J., Wolfson S.K., and Kuller L.H. The relationship between ankle-arm index and mortality in older men and women. J. Am. Geriatr. Soc. 41 (1993) 523-530
9. McDermott M.M., Liu K., Criqui M.H., Ruth K., Goff D., Saad M.F., et al. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 162 (2005) 33-41
10. Tsai A.W., Folsom A.R., Rosamond W.D., and Jones D.W. Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke 32 (2001) 1721-1724
11. Pyorala K., Laakso M., and Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab. Rev. 3 (1987) 463-524
12. Yu H.I., Sheu W.H., Song Y.M., Liu H.C., Lee W.J., and Chen Y.T. C-reactive protein and risk factors for peripheral vascular disease in subjects with type 2 diabetes mellitus. Diabet. Med. 21 (2004) 336-341
13. Katsilambros N.L., Tsapogas P.C., Arvanitis M.P., Tritos N.A., Alexiou Z.P., and Rigas K.L. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons. Diabet. Med. 13 (1996) 243-246
14. MacGregor A.S., Price J.F., Hau C.M., Lee A.J., Carson M.N., and Fowkes F.G. Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study. Diabetes Care 22 (1999) 453-458
15. Creager M.A. Medical management of peripheral arterial disease. Cardiol. Rev. 9 (2001) 238-245
16. Murabito J.M., D'Agostino R.B., Silbershatz H., and Wilson W.F. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation 96 (1997) 44-49
17. Bowlin S.J., Medalie J.H., Flocke S.A., Zyzanski S.J., and Goldbourt U. Epidemiology of intermittent claudication in middle-aged men. Am. J. Epidemiol. 140 (1994) 418-430
18. Ridker P.M., Stampfer M.J., and Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285 (2001) 2481-2485
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
20. Verges B.L. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab. 25 (1999) 32-40
21. Kreisberg R.A. Diabetic dyslipidemia. Am. J. Cardiol. 82 (1998) 67U-73U
22. Lee I.T., Lin T.M., Lee W.J., Ou H.C., Chien Y.H., Lee W.L., et al. Hypercholesterolemia, not metabolic syndrome, related to adhesion of monocytes to cultured endothelium in nondiabetic subjects. Metabolism 54 (2005) 1467-1471
23. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
24. Dandona P., and Aljada A. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis. Am. J. Cardiol. 90 (2002) 27G-33G
25. Rosenson R.S., and Koenig W. Utility of inflammatory markers in the management of coronary artery disease. Am. J. Cardiol. 92 (2003) 10i-18i
26. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
27. O'Hare A.M., Rodriguez R.A., and Bacchetti P. Low ankle-brachial index associated with rise in creatinine level over time: results from the atherosclerosis risk in communities study. Arch. Intern. Med. 165 (2005) 1481-1485
28. Wattanakit K., Folsom A.R., Selvin E., Weatherley B.D., Pankow J.S., Brancati F.L., et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 180 (2005) 389-397
29. Kallio M., Forsblom C., Groop P.H., Groop L., and Lepantalo M. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care 26 (2003) 1241-1245
30. Lip G.Y., and Beevers D.G. Epidemiology of aortic aneurysm and peripheral vascular disease may show ethnic differences. BMJ 313 (1996) 173
31. Makin A., Silverman S., and Lip G.Y. Ethnic differences in peripheral vascular disease. Int. J. Clin. Pract. 56 (2002) 605-608
32. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
33. Brisk P.S., and Alerbs J.J. Precipitation methods for quantification of lipoprotein. In: Albers J.J., and Segrest J.P. (Eds). Methods in Enzymology (1986), Academic, London 78-100
34. Friedwald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
35. Wang T.D., Chen W.J., Chien K.L., Seh-Yi Su S.S., Hsu H.C., Chen M.F., et al. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population. Am. J. Cardiol. 88 (2001) 737-743
36. Ridker P.M., Rifai N., Cook N.R., Bradwin G., and Buring J.E. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294 (2005) 326-333
37. Lee I.T., Sheu W.H., Lin S.Y., Lee W.J., Song Y.M., and Liu H.C. Simvastatin reduces plasma concentration of high-sensitivity C-reactive protein in type 2 diabetic patients with hyperlipidemia. J. Diabetes Complications 16 (2002) 382-385
38. Tan C.E., Ma S., Wai D., Chew S.K., and Tai E.S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 27 (2004) 1182-1186
39. Zimmet P., Magliano D., Matsuzawa Y., Alberti G., and Shaw J. The metabolic syndrome: a global public health problem and a new definition. J. Atheroscler. Thromb. 12 (2005) 295-300
40. The Global Lower Extremity Amputation Study Group. Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia. Br. J. Surg. 87 (2000) 328-337
41. McDermott M.M., Liu K., Greenland P., Guralnik J.M., Criqui M.H., Chan C., et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 292 (2004) 453-461
42. Holman R.R., Coleman R.L., Shine B.S., and Stevens R.J. Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes. Diabetes Care 28 (2005) 1796-1797
43. Jiang R., Schulze M.B., Li T., Rifai N., Stampfer M.J., Rimm E.B., et al. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 27 (2004) 1991-1997
44. Cheng S.W., Ting A.C., Lau H., and Wong J. Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong. World J. Surg. 23 (1999) 202-206
45. Kennedy M., Solomon C., Manolio T.A., Criqui M.H., Newman A.B., Polak J.F., et al. Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study. Arch. Intern. Med. 165 (2005) 1896-1902
46. Fowkes F.G., Housley E., Riemersma R.A., Macintyre C.C., Cawood E.H., Prescott R.J., et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am. J. Epidemiol. 135 (1992) 331-340
47. Leng G.C., Lee A.J., Fowkes F.G., Lowe G.D., and Housley E. The relationship between cigarette smoking and cardiovascular risk factors in peripheral arterial disease compared with ischaemic heart disease. The Edinburgh Artery Study. Eur. Heart J. 16 (1995) 1542-1548
48. Price J.F., Mowbray P.I., Lee A.J., Rumley A., Lowe G.D., and Fowkes F.G. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur. Heart J. 20 (1999) 344-353
49. Chen J.W., Gall M.A., Deckert M., Jensen J.S., and Parving H.H. Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. BMJ 311 (1995) 1405-1406
50. Jager A., van Hinsbergh V.W., Kostense P.J., Emeis J.J., Yudkin J.S., Nijpels G., et al. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 3071-3078
51. Hozawa A., Ohmori K., Kuriyama S., Shimazu T., Niu K., Watando A., et al. C-reactive protein and peripheral artery disease among Japanese elderly: the Tsurugaya Project. Hypertens. Res. 27 (2004) 955-961
52. Iglseder B., Cip P., Malaimare L., Ladurner G., and Paulwebe B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 36 (2005) 1212-1217
53. McDermott M.M., Green D., Greenland P., Liu K., Criqui M.H., Chan C., et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am. J. Cardiol. 92 (2003) 194-199
54. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
55. Gorter P.M., Olijhoek J.K., van der Graaf Y., Algra A., Rabelink T.J., and Visseren F.L. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis 173 (2004) 363-369
56. Costa L.A., Canani L.H., Lisboa H.R., Tres G.S., and Gross J.L. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet. Med. 21 (2004) 252-255
57. Wierzbicki A.S., Nishtar S., Lumb P.J., Lambert-Hammill M., Turner C.N., Crook M.A., et al. Metabolic syndrome and risk of coronary heart disease in a Pakistani cohort. Heart 91 (2005) 1003-1007
58. Anderson J.L., Horne B.D., Jones H.U., Reyna S.P., Carlquist J.F., Bair T.L., et al. Intermountain Heart Collaborative (IHC) Study. Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?. Cardiology 101 (2004) 185-193
59. Sone H., Mizuno S., Fujii H., Yoshimura Y., Yamasaki Y., Ishibashi S., et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 28 (2005) 1463-1471
60. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov Jr. S., Insull W., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92 (1995) 1355-1374
61. Tseng C.H., Tseng C.P., Tai T.Y., and Chong C.K. Effect of angiotensin blockade on the association between albuminuria and peripheral arterial disease in elderly Taiwanese patients with type 2 diabetes mellitus. Circ. J. 69 (2005) 965-970
62. Wilmshurst P. Ethnic differences in aortic aneurysm and peripheral vascular disease. Authors' data are inadequate. BMJ 313 (1996) 1084
63. Aboyans V., Criqui M.H., Denenberg J.O., Knoke J.D., Ridker P.M., and Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 113 (2006) 2623-2629
64. Fine J.J., Hopkins C.B., and Hall P.A. Abnormal ankle brachial indices may predict cardiovascular disease among diabetic patients without known heart disease. Circ. J. 69 (2005) 798-801
65. Hayashi C., Ogawa O., Kubo S., Mitsuhashi N., Onuma T., and Kawamori R. Ankle brachial pressure index and carotid intima-media thickness as atherosclerosis markers in Japanese diabetics. Diab. Res. Clin. Pract. 66 (2004) 269-275
66. Weatherley B.D., Nelson J.J., Heiss G., Chambless L.E., Sharrett A.R., Nieto F.J., et al. The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study, 1987-2001. BMC Cardiovasc. Disord. 7 (2007) 3